stockportfolio.pro
Henry Schein, Inc. (HSIC)
Healthcare · Medical Distribution · NasdaqGS
Henry Schein, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.57B | $12.46B | $13.20B | $9.99B | $10.12B | $12.40B | $12.65B | $12.34B | $12.67B | $13.18B |
| Gross profit | $3.23B | $2.75B | $2.91B | $3.09B | $2.82B | $3.67B | $3.83B | $3.86B | $4.02B | $4.11B |
| Net income | $506.78M | $406.30M | $535.88M | $694.73M | $404.00M | $631.00M | $538.00M | $416.00M | $390.00M | $398.00M |
| Net margin | 4.4% | 3.3% | 4.1% | 7.0% | 4.0% | 5.1% | 4.3% | 3.4% | 3.1% | 3.0% |
Source: Henry Schein, Inc. SEC filings (10-K). 18 years of history available in the interactive view.
What growth is priced into HSIC stock?
At today's market cap of $9.12B, Henry Schein, Inc. is priced for free-cash-flow growth of about 4.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $573.00M from the FY ending 2025-12-31). For comparison, free cash flow actually grew 0.8%/yr over the last five fiscal years and revenue 5.4%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 18 years of Henry Schein, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track HSIC in your portfolio →
Henry Schein, Inc. financial history by metric
About Henry Schein, Inc.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Henry Schein, Inc. — frequently asked questions
What is Henry Schein, Inc.'s revenue?
Henry Schein, Inc. (HSIC) reported revenue of $13.18B for fiscal year 2025, up 4.0% from the prior year, according to its SEC filings.
Is Henry Schein, Inc. profitable?
Yes. HSIC earned net income of $398.00M in fiscal 2025, a net margin of 3.0%.
What is HSIC's P/E ratio?
Henry Schein, Inc. trades at a price-to-earnings ratio of about 24.2 based on the latest data in our nightly-refreshed cache.
How fast is Henry Schein, Inc. growing?
HSIC's revenue grew at roughly 5.4% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Henry Schein, Inc. have?
As of fiscal year 2025, HSIC carried roughly $764.00M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Henry Schein, Inc.'s gross margin?
HSIC's gross margin was 31.1% in fiscal 2025 — gross profit of $4.11B on revenue of $13.18B.
What is Henry Schein, Inc.'s market cap?
Henry Schein, Inc. (HSIC) has a market capitalization of about $9.12B, based on the latest data in our nightly-refreshed cache.
When does Henry Schein, Inc.'s fiscal year end?
HSIC's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into HSIC stock?
At today's market cap of $9.12B, Henry Schein, Inc. is priced for free-cash-flow growth of about 4.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $573.00M from the FY ending 2025-12-31). For comparison, free cash flow actually grew 0.8%/yr over the last five fiscal years and revenue 5.4%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Henry Schein, Inc.'s official SEC filings (10-K and 10-Q), covering 18 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.